Lamitrin Tablet

About Lamitrin 25 mg Tablet

Lamitrin 25 mg Tablet is a medicine from Advanced Chemical Industries PLC that contains the active ingredient lamotrigine. It belongs to the primary anti-epileptic drug group and is used in the treatment of certain seizure types and in bipolar disorder in adults.

There are 4 brands of Lamotrigine listed in Bangladesh. 1 of them has a lower unit price than Lamitrin.

What is Lamitrin 25 mg Tablet?

Lamitrin 25 mg Tablet is an anti-epileptic medicine made by Advanced Chemical Industries PLC. Its active ingredient is lamotrigine, which acts on the nervous system to help control certain kinds of seizures. It is used as part of combination therapy for some seizure types in patients aged two years and older, and on its own in patients aged sixteen years and older. It is also used in adults with bipolar disorder. The tablet comes in a 3 x 10 pack. The doctor decides the dose and course for each person.

Uses of Lamitrin

Lamitrin is used with other medicines to treat partial-onset seizures, primary generalized tonic-clonic seizures and generalized seizures of Lennox-Gastaut syndrome in patients aged two years and older. It is also used alone for epilepsy in patients aged sixteen years and older, and for bipolar disorder in adults. Only a doctor can decide whether it suits a particular person.

How to use Lamitrin

Take Lamitrin exactly as the doctor tells you. The doctor sets the dose and the course, and may start with a low amount and adjust it over time, sometimes based on other medicines you take. Swallow the tablet as directed. Do not change the dose or stop the medicine on your own, since stopping suddenly can be harmful. Ask your doctor or pharmacist if you are unsure how to take it.

Side effects of Lamitrin

Some people taking Lamitrin may have dizziness, tremor, headache, rash, blurred vision, fever, clumsiness, abdominal pain, infections, sleepiness, back pain, vomiting, diarrhoea, tiredness, trouble sleeping, dry mouth, a stuffy nose or a sore throat. A rash can sometimes be serious, so tell your doctor about any rash. Report other effects to your doctor or pharmacist, who can advise you.

Safety and precautions

Lamitrin can cause serious skin rashes, blood disorders, suicidal behaviour and aseptic meningitis, so tell your doctor about any rash or unusual symptoms. It is pregnancy category C and passes into breast milk; whether to continue breastfeeding while taking it should be discussed with the doctor. Ask your doctor first if you are pregnant, planning a pregnancy, breastfeeding, or have liver or kidney problems. The doctor decides if it is suitable for you.

Frequently asked questions

What is the price of Lamitrin 25 mg Tablet?

The listed price is ৳ 11.5. Ask your pharmacist about the current price and availability, as prices can change.

Which medicines may interact with Lamitrin?

Lamitrin may interact with oral contraceptives, atazanavir/ritonavir, carbamazepine, levetiracetam, lithium, lopinavir/ritonavir, olanzapine, phenobarbital/primidone, phenytoin and pregabalin, among others. Tell your doctor about all medicines you take, including herbal products, so the dose can be adjusted if needed.

What is Lamitrin used for and what kind of medicine is it?

Lamitrin is an anti-epileptic medicine containing lamotrigine. It is used with other medicines for certain seizure types in patients aged two years and older, alone for epilepsy in those aged sixteen and older, and for bipolar disorder in adults. The doctor decides the dose and course.

Who should avoid Lamitrin or ask the doctor first?

Ask your doctor first if you are pregnant, planning a pregnancy, breastfeeding, or have liver or kidney problems. Tell the doctor about any rash, mood changes or unusual symptoms. Only the doctor can decide whether Lamitrin is suitable for you.

Also available as

50 mg (Tablet)

Indications

Lamotrigine is indicated for:

Epilepsy-combination therapy in patients aged 2 years and older:
  • partial-onset seizures
  • primary generalized tonic-clonic seizures
  • generalized seizures of Lennox-Gastaut syndrome
Epilepsy-monotherapy in patients aged 16 years and older.

Adults with Bipolar Disorder.

Pharmacology

The exact mechanism of action of lamotrigine is not fully elucidated, as it may exert cellular activities that contribute to its efficacy in a range of conditions. Although chemically unrelated, lamotrigine actions resemble those of phenytoin and carbamazepine, inhibiting voltage-sensitive sodium channels, stabilizing neuronal membranes, thereby modulating the release of presynaptic excitatory neurotransmitters.

Lamotrigine likely acts by inhibiting sodium currents by selective binding to the inactive sodium channel, suppressing the release of the excitatory amino acid, glutamate. The mechanism of action of lamotrigine in reducing anticonvulsant activity is likely the same in managing bipolar disorder. Studies on lamotrigine have identified its binding to sodium channels in a fashion similar to local anesthetics, which could explain the demonstrated clinical benefit of lamotrigine in some neuropathic pain states.

Lamotrigine displays binding properties to several different receptors. In laboratory binding assays, it demonstrates weak inhibitory effect on the serotonin 5-HT3 receptor. Lamotrigine also weakly binds to Adenosine A1/A2 receptors, α1/α2/β adrenergic receptors, dopamine D1/D2 receptors, GABA A/B receptors, histamine H1 receptors, κ-opioid receptor (KOR), mACh receptors and serotonin 5-HT2 receptors with an IC50>100 µM. Weak inhibitory effects were observed at sigma opioid receptors. An in vivo study revealed evidence that lamotrigine inhibits Cav2.3 (R-type) calcium currents, which may also contribute to its anticonvulsant effects.

Dosage & Administration

Epilepsy-
Table-1: Escalation Regimen for Lamotrigine in Patients Older than 12 Years with Epilepsy

Weeks 1 & 2:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 25 mg every day
  • In patients taking Valproate: 25 mg every other day
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 50 mg/day
Weeks 3 & 4:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 50 mg/day
  • In patients taking Valproate: 25 mg every day
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 100 mg/day (in 2 divided doses)
Week 5 onward to maintenance:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: Increase by 50 mg/day every 1 to 2 weeks
  • In patients taking Valproate: Increase by 25 to 50 mg/day every 1 to 2 weeks
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: Increase by 100 mg/day every 1 to 2 weeks
Usual maintenance dose:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 225 to 375 mg/day (in 2 divided doses)
  • In patients taking Valproate: 100 to 200 mg/day with Valproate alone 100 to 400 mg/day with Valproate and other drugs that induce glucuronidation (in 1 or 2 divided doses)
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 300 to 500 mg/day (in 2 divided doses)
Table-2: Escalation Regimen for Lamotrigine in Patients Aged 2 to 12 Years with Epilepsy

Weeks 1 & 2:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 0.3 mg/kg/day in 1 or 2 divided doses
  • In patients taking Valproate: 0.15 mg/kg/day in 1 or 2 divided doses
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 0.6 mg/kg/day (in 2 divided doses)
Weeks 3 & 4:
In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 0.6 mg/kg/day (in 2 divided doses)
  • In patients taking Valproate: 0.3 mg/kg/day in 1 or 2 divided doses
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 1.2 mg/kg/day (in 2 divided doses)
Week 5 onward to maintenance:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: The dose should be increased every 1 to 2 weeks as follows-calculate 0.6 mg/kg/day
  • In patients taking Valproate: The dose should be increased every 1 to 2 weeks as follows-calculate 0.3 mg/kg/day
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: The dose should be increased every 1 to 2 weeks as follows-calculate 1.2 mg/kg/day
Usual maintenance dose:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 4.5 to 7.5 mg/kg/day (maximum 300 mg/day in 2 divided doses)
  • In patients taking Valproate: 1 to 3 mg/kg/day with Valproate alone 1 to 5 mg/kg/day (maximum 200 mg/day in 1 or 2 divided doses)
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 5 to 15 mg/kg/day (maximum 400 mg/day in 2 divided doses)
Table-3: The Initial Weight-Based Dosing Guide for Patients Aged 2 to 12 Years Taking Valproate (Weeks 1 to 4) with Epilepsy

Weeks 1 & 2:
  • If the patients weight is 6.7 kg to 14 kg: 2 mg every other day
  • If the patients weight is 14.1 kg to 27 kg: 2 mg every day
  • If the patients weight is 27.1 kg to 34 kg: 4 mg every day
  • If the patients weight is 34.1 kg to 40 kg: 5 mg every day
Weeks 3 & 4:
  • If the patients weight is 6.7 kg to 14 kg: 2 mg every day
  • If the patients weight is 14.1 kg to 27 kg: 4 mg every day
  • If the patients weight is 27.1 kg to 34 kg: 8 mg every day
  • If the patients weight is 34.1 kg to 40 kg: 10 mg every day
Bipolar disorder-

Table-4: Escalation Regimen for Lamotrigine in Adults with Bipolar Disorder
Weeks 1 & 2:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 25 mg daily
  • In patients taking Valproate: 25 mg every other day
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 50 mg daily
Weeks 3 & 4:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 50 mg daily
  • In patients taking Valproate: 25 mg daily
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 100 mg daily (in divided doses)
Week 5:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 100 mg daily
  • In patients taking Valproate: 50 mg daily
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 200 mg daily (in divided doses)
Week 6:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 200 mg daily
  • In patients taking Valproate: 100 mg daily
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: 300 mg daily (in divided doses)
Week 7:
  • In patients not taking Carbamazepine, Phenytoin, Phenobarbital, Primidone or Valproate: 200 mg daily
  • In patients taking Valproate: 100 mg daily
  • In patients taking Carbamazepine, Phenytoin, Phenobarbital or Primidone and not taking Valproate: up to 400 mg daily (in divided doses)

Interaction

Lamotrigine interacts with Oral contraceptives, Atazanavir/ritonavir, Carbamazepine, Levetiracetam, Lithium, Lopinavir/ritonavir , Olanzapine, Phenobarbital/primidone , Phenytoin, Pregabalin etc.

Side Effects

Common side effects of Lamotrigine include-dizziness, tremor, headache, rash, blurred vision, fever, lack of coordination, abdominal pain, infections, sleepiness, back pain, vomiting, diarrhea, tiredness, insomnia, dry mouth, stuffy nose, sore throat.

Pregnancy & Lactation

Pregnancy Category C. Lamotrigine is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from Lamotrigine, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Serious skin rashes, Blood Dyscrasias, Suicidal Behavior, Aseptic Meningitis can occur in both adult and pediatric population.

Overdose Effects

Overdose has resulted in ataxia, nystagmus, seizures (including tonic-clonic seizures), decreased level of consciousness, coma, and intraventricular conduction delay.

Storage Conditions

Store below 30°C. Protect from light and moisture. Keep out of the reach of children.

Alternative brands of Lamotrigine

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.